National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers marketing experience solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools through a multi-mode digital platform. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; employee experience solutions that give care teams information, tools and support needed to create engagement and open communication throughout the employee lifecycle; and consumer experience solutions which capture feedback across the healthcare journey, drive choice to build volume, and co-design experiences and services through community insights. Additionally, the company offers Huey AI, an AI engine for Human Understanding that serves as a healthcare experience management companion; and governance solutions for not-for-profit health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

National Research Corporation

In a report released today, Adam Maeder from Piper Sandler maintained a Buy rating on Neuronetics, with a price target of $3.00. Maeder covers the ...

Neuronetics (STIM) Receives a Buy from Piper Sandler

In a report released today, Andrea James from Colliers Securities maintained a Hold rating on Generac Holdings, with a price target of $222.00. Acc...

Generac Holdings (GNRC) Gets a Hold from Colliers Securities

Neuronetics ( ($STIM) ) has provided an update. On March 12, 2026, Neuronetics’ board appointed veteran medtech executive Daniel L. Reuvers as pres...

Current Quarter	$NA	Next Quarter	$NA
Current Year	$NA	Next Year	$NA
QoQ Growth	NaN%	YoY Growth	NaN%
3Y EPS CAGR	-10.6%	Target Price	$NaN
Consensus	N/A	Upside	N/A

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NRC	$17.26	0.00%	82.43K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NRC	$17.26	0%	82.43K
3
4
5
6

NRC

NRC

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get National Research Corporation Data in Excel

Get National Research Corporation Data in Excel